Amid the exit plan of Glaxo Consumer Nigeria Plc, minority shareholders of the pharmaceutical firm have agreed that the firm’s share should be acquired at 17.42 per unit to finalize its delisting from the Nigerian Exchange Limited. The company disclosed this in a corporate notice to NGX on Friday. Accordingly, the shareholders approved the share buyback rate, among other resolutions, at the court-ordered meeting between the parties to the Scheme of Arrangement. “Other than Setfirst Limited and SmithKline Beecham Limited, who have notified the company that they have elected not to receive their…